CELGENE CORPORATION et al v. PRIME THERAPEUTICS LLC
| CELGENE CORPORATION and BRISTOL-MYERS SQUIBB COMPANY |
| PRIME THERAPEUTICS LLC |
| 2:2024cv04479 |
| April 2, 2024 |
| US District Court for the District of New Jersey |
| Other Statutory Actions |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 2, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 16 Certified Copy of Transfer Order and docket received, Case transferred in from District of Delaware; Case Number 1:24-mc-00131. Original file certified copy of transfer order and docket sheet received. |
Filing 15
SO ORDERED Granting #14 Stipulation and Proposed Order for Transfer of Venue and Extension of Time (*Reset Briefing Schedule: re #1 MOTION to Compel. Answering Brief due 4/11/2024). Signed by Judge Richard G. Andrews on 4/2/2024. (nms)
|
| Case transferred to District of District of New Jersey. (nms) |
| Filing 14 STIPULATION and Proposed Order for Transfer of Venue and Extension of Time, by Prime Therapeutics LLC. (Glorioso, Alessandra) Modified on 3/28/2024 (nms). |
| Filing 13 MOTION for Pro Hac Vice Appearance of Attorney Jaime Stilson and Alyssa Schaefer - filed by Prime Therapeutics LLC. (Glorioso, Alessandra) |
|
Filing 12
ORAL ORDER: The Motion for Pro Hac Vice Appearance of Attorney Jaime Stilson and Alyssa Schaefer (D.I. #11 ) is DENIED without prejudice and with leave to renew. Pro hac motions need to include independent certifications by each attorney being moved. The motion presented had a joint certification for all. Ordered by Judge Richard G. Andrews on 3/26/2024. (nms)
|
| Filing 11 MOTION for Pro Hac Vice Appearance of Attorney Jaime Stilson and Alyssa Schaefer - filed by Prime Therapeutics LLC. (Glorioso, Alessandra) |
| Filing 10 Pro Hac Vice Fee - Credit Card Payment received for Jaime Stilson and Alyssa Schaefer. ( Payment of $ 100, receipt number ADEDC-4370724).(Glorioso, Alessandra) |
| Filing 9 NOTICE of Appearance by Alessandra Glorioso and Eric Lopez Schnabel on behalf of Prime Therapeutics LLC. (Glorioso, Alessandra) Modified on 3/26/2024 (nms). |
| Pro Hac Vice Attorney Jaime Stilson for Prime Therapeutics LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) |
|
SO ORDERED, re #13 MOTION for Pro Hac Vice Appearance of Attorney Jaime Stilson and Alyssa Schaefer, filed by Prime Therapeutics LLC. Signed by Judge Richard G. Andrews on 3/26/2024. (nms)
|
| Pro Hac Vice Attorney Nicholas C. Suellentrop for Bristol-Myers Squibb Company and Celgene Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Filing 8 Pro Hac Vice Fee - Credit Card Payment received for Nicholas Suellentrop. ( re #7 MOTION for Pro Hac Vice Appearance of Attorney Nicholas Suellentrop )( Payment of $ 50, receipt number ADEDC-4367262).(Ewing, Alexandra) |
| Filing 7 MOTION for Pro Hac Vice Appearance of Attorney Nicholas Suellentrop - filed by Bristol-Myers Squibb Company, Celgene Corporation. (Attachments: #1 Certification - Suellentrop)(Ewing, Alexandra) |
|
SO ORDERED, re #7 MOTION for Pro Hac Vice Appearance of Attorney Nicholas Suellentrop, filed by Celgene Corporation, Bristol-Myers Squibb Company. Signed by Judge Richard G. Andrews on 3/21/2024. (nms)
|
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Remark: Case submitted for routine judicial assignment. (nmg) |
| Filing 6 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bristol-Myers Squibb Company for Celgene Corporation filed by Bristol-Myers Squibb Company, Celgene Corporation. (apk) |
| Filing 4 DECLARATION of Nicholas C. Suellentrop re #1 MOTION to Compel Compliance with Subpoena, by Bristol-Myers Squibb Company, Celgene Corporation. (Attachments: #1 Certificate of Service)(apk) Modified on 3/20/2024 (nms). |
| Filing 3 OPENING BRIEF in Support of D.I. #1 MOTION to Compel Compliance with Subpoena filed by Bristol-Myers Squibb Company, Celgene Corporation.Answering Brief/Response due date per Local Rules is 3/27/2024. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Certificate of Service)(apk) |
| Filing 2 MOTION to Transfer Case to U.S. District Court for the District of New Jersey - filed by Bristol-Myers Squibb Company, Celgene Corporation. (Attachments: #1 Text of Proposed Order, #2 Certificate of Service)(apk) |
| Filing 1 MOTION to Compel Compliance with Subpoena (Filing Fee $52, Receipt Number: ADEDC-4360952) - filed by Bristol-Myers Squibb Company, Celgene Corporation. (Attachments: #1 Text of Proposed Order, #2 Certificate of Service, #3 Civil Cover Sheet)(apk) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
